Cita APA

Adamson, A. W., Ding, Y. C., Mendez‐Dorantes, C., Bailis, A. M., Stark, J. M., & Neuhausen, S. L. (2020). The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations. Mol Oncol.

Chicago Style Citation

Adamson, Aaron W., Yuan Chun Ding, Carlos Mendez‐Dorantes, Adam M. Bailis, Jeremy M. Stark, i Susan L. Neuhausen. "The RAD52 S346X Variant Reduces Risk of Developing Breast Cancer in Carriers of Pathogenic Germline BRCA2 Mutations." Mol Oncol 2020.

Cita MLA

Adamson, Aaron W., et al. "The RAD52 S346X Variant Reduces Risk of Developing Breast Cancer in Carriers of Pathogenic Germline BRCA2 Mutations." Mol Oncol 2020.